Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Deeks, Shelley L ^a,b   Lim, Gillian H ^a   Simpson, Mary Anne ^c   Rosella, Laura ^a,b   MacKie, Christopher O ^d,e   Achonu, Camille ^a   Crowcroft, Natasha S ^a,b,f  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^d City of Hamilton Public Health Services   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; EPIDEMIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MALE; PANDEMIC; PREVENTIVE HEALTH SERVICE; RISK ASSESSMENT; SAFETY; UTILIZATION REVIEW;

EPIDEMIOLOGIC STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; ONTARIO; PANDEMICS; RISK ASSESSMENT; SAFETY MANAGEMENT;

EID: 79955977912     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-329     Document Type: Article

References (25)

1. Interim order respecting the sale of the vaccine for the novel influenza a H1N1 virus. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/legislation/ interimorders-arretesurgence/vaccin-eng.php
2. Health officials scramble to counter H1N1 myths; Safety and effectiveness of vaccine emphasized in effort to reassure skeptics as conspiracy theories go viral. The Globe and Mail, Reported by Caroline Alphonso 2009
3. Nearly half of Canadians won't get H1N1 shot: poll; Health officials try to counter fear, confusion. Ottawa Citizen, Reported by Meagan Fitzpatrick 2009
4. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. LB Schonberger DJ Bregman JZ Sullivan-Bolyai RA Keenlyside DW Ziegler HF Retailliau DL Eddins JA Bryan, Am J Epidemiol 1979 110 105 123 463869 (Pubitemid 10209694)
5. Vaccines and Guillain-Barré syndrome. P Haber J Sejvar Y Mikaeloff F DeStefano, Drug Saf 2009 32 309 323 10.2165/00002018-200932040-00005 19388722
6. Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study. LJ Hauck C White TE Feasby DW Zochodne LW Svenson MD Hill, J Neurol Neurosurg Psychiatry 2008 79 318 320 10.1136/jnnp.2007.118810 17595235 (Pubitemid 351303392)
7. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. DN Juurlink TA Stukel J Kwong A Kopp A McGeer RE Upshur DG Manuel R Moineddin K Wilson, Arch Intern Med 2006 166 2217 2221 10.1001/archinte.166.20.2217 17101939 (Pubitemid 44748768)
8. Guillain-Barré syndrome and influenza virus infection. V Sivadon-Tardy D Orlikowski R Porcher T Sharshar MC Durand V Enouf F Rozenberg C Caudie D Annane S van der Werf P Lebon JC Raphal JL Gaillard E Gault, Clin Inf Dis 2009 48 48 56 10.1086/594124
9. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. T Lasky GJ Terracciano L Magder CL Koski M Ballesteros D Nash S Clark P Haber PD Stolley LB Schonberger RT Chen, N Engl J Med 1998 339 1797 1802 10.1056/NEJM199812173392501 9854114 (Pubitemid 29005783)
10. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database. J Stowe N Andrews L Wise E Miller, Am J Epidemiol 2009 169 382 388 19033158
11. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. S Black J Eskola CA Siegrist N Halsey N Macdonald B Law E Miller N Andrews J Stowe D Salmon K Vannice HS Izurieta A Akhtar M Gold G Oselka P Zuber D Pfeifer C Vellozzi, Lancet 2009 374 2115 2122 19880172
12. Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual. Statistics Canada, CANSIM Table 051-0001
13. Distribution of the H1N1 vaccine. Public Health Agency of Canada, http://origin.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/dist-eng.php
14. Ontario Ministry of Health and Long-Term Care Fact Sheet: You Call the Shot: H1N1 Public Education Campaign. http://www.health.gov.on.ca/en/news/ release/2009/dec/fact-20091218.aspx
15. The H1N1 Pandemic - How Ontario Fared: A Report by Ontario's Chief Medical Officer of Health. http://www.health.gov.on.ca/en/public/publications/ ministry-reports/cmoh-h1n1/cmoh-h1n1-20100602.pdf
16. Self reported influenza A (H1N1) 2009 monovalent vaccination coverage for Ontario, Canada. J Foisy LC Rosella R Sanderson JS Hamid B Dhar NS Crowcroft, Health Reports
17. H1N1 vaccination. H Gilmour N Hofmann, Health Reports 21 1 7
18. A seroprevalence study of pandemic influenza A H1N1 among Ontarians. C Achonu M LaFreniere J Gubbay L Rosella S Deeks T Mazzulli A Rebbapragada I Johnson D Willison C Johnson A Chiodo L Shi J Willmore C Yue J Tom N Crowcroft, European Scientific Conference on Applied Infectious Disease Epidemiology Abstract Book. Lisbon 2010 50
19. Vaccine Surveillance Report - Adverse Events following Immunization. Public Health Agency of Canada, 2010 http://www.phac-aspc.gc.ca/alert-alerte/ h1n1/vacc/addeve-eng.php
20. Final summary of adverse drug reaction reports in Sweden with Pandemrix through October 2009 - mid April 2010. Läkemedelverket Medical Products Agency, 2010 http://www.lakemedelsverket.se/upload/eng-mpa-se/ Pandemrix%20ADRs%20in%20Sweden%2015%20april%202010.pdf
21. Final Public Summary: UK Suspected Adverse Reaction Analysis Swine Flu (H1N1) Vaccines - Celvapan and Pandemrix - March 26, 2010. Medicines and Healthcare Products Regulatory Agency, http://www.mhra.gov.uk/home/groups/pl-p/ documents/websiteresources/con078911.pdf
22. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. C Vellozzi KR Broder P Haber A Guh M Nguyen M Cano P Lewis MM McNeil M Bryant J Singleton D Martin F DeStefano, Vaccine 2010 28 7248 7255 10.1016/j.vaccine.2010.09.021 20850534
23. Preliminary results: Surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. CDC, MMWR 2010 59 657 661 20520590
24. Guillain-Barré syndrome after exposure to influenza virus. HC Lehmann HP Hartung BC Kieseier RAC Hughes, Lancet Infect Dis 2010 10 643 651 10.1016/S1473-3099(10)70140-7 20797646
25. Resident gets Guillain-Barré after H1N1 shot. The Hamilton Spectator, Reported by Joanna Frketich 2009